Does VONOPRAZAN Cause Product dose omission issue? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Product dose omission issue have been filed in association with VONOPRAZAN (VOQUEZNA). This represents 2.4% of all adverse event reports for VONOPRAZAN.
49
Reports of Product dose omission issue with VONOPRAZAN
2.4%
of all VONOPRAZAN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Product dose omission issue From VONOPRAZAN?
Of the 49 reports, 6 (12.2%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VONOPRAZAN. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does VONOPRAZAN Cause?
Drug ineffective (305)
Off label use (188)
Gastrooesophageal reflux disease (162)
Nausea (138)
Diarrhoea (115)
Abdominal pain upper (107)
Dyspepsia (90)
Headache (80)
Abdominal distension (68)
Dizziness (68)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which VONOPRAZAN Alternatives Have Lower Product dose omission issue Risk?
VONOPRAZAN vs VONOPRAZAN FUMURATE
VONOPRAZAN vs VORAPAXAR
VONOPRAZAN vs VORASIDENIB
VONOPRAZAN vs VORETIGENE NEPARVOVEC-RZYL
VONOPRAZAN vs VORICONAZOLE